- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06147076
Social Support Counseling Intervention for Kidney Transplant Candidates (JtT)
December 13, 2024 updated by: Hennepin Healthcare Research Institute
Journey to Transplant: Virtual Coaching for Potential Kidney Transplant Patients and Their Social Support Networks
Virtual Coaching for Potential Kidney Transplant Patients
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Individuals who are eligible for kidney transplant will be recruited by phone or email and randomized into two groups, control and interventional counseling.
The control group will be given a simple survey to fill and return while the interventional counseling will go through a group education and counseling session along with members of their social support networks.
The interventional counseling will then complete a pre and post survey (same as control group).
Survey answers will be recorded within REDCAP.
Study Type
Interventional
Enrollment (Estimated)
86
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Allyson Hart, MD
- Phone Number: 612-873-6998
- Email: allyson.hart@hcmed.org
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55415
- Recruiting
- Hennepin Healthcare
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion
- Determined by transplant center to be suitable for continuation in evaluation for listing (or a member of that person's social support network)
- 18 Years of age or older
- English-speaking
- Willingness to participate with at least 2 social network members in the session and have calculator results shown to social network members (if a patient)
- Able to provide informed consent
Exclusion
- Prisoners
- Individuals with impaired ability to consent
- Pregnant females.
- Patients who choose to opt out of research.
- Non-English speaking
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual Pre-Transplant Counseling Intervention
Participants in control arm will undergo usual pre-transplant counseling as per the standard of care.
|
|
|
Experimental: Social Support Network Counseling Intervention
Participants in the intervention arm will undergo an additional pretransplant counseling session along with members of their social support networks after their initial transplant evaluation and counseling.
|
Social support counseling intervention for kidney transplant candidates along with their social support networks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correct Answers on Knowledge of Kidney Transplant Options Assessment
Time Frame: one month
|
Questionnaire
|
one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Decisional Conflict Scores
Time Frame: one month
|
Questionnaire
|
one month
|
|
Social Support Scores
Time Frame: one month
|
Questionnaire
|
one month
|
|
Knowledge Scores
Time Frame: one month
|
Questionnaire
|
one month
|
|
Hearth Hope Index
Time Frame: one month
|
Questionnaire
|
one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 20, 2024
Primary Completion (Estimated)
May 1, 2026
Study Completion (Estimated)
September 1, 2026
Study Registration Dates
First Submitted
November 20, 2023
First Submitted That Met QC Criteria
November 20, 2023
First Posted (Actual)
November 27, 2023
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 13, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1R01DK135730-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
There might be an exchange of data with our collaborators with the study at the University of Minnesota-Twin Cities
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.